Association between most prevalent side effects and number of chemotherapy sessions in women with breast neoplasia
International Journal of Development Research
Association between most prevalent side effects and number of chemotherapy sessions in women with breast neoplasia
Received 30th August, 2019; Received in revised form 22nd September, 2019; Accepted 14th October, 2019; Published online 30th November, 2019
Copyright © 2019, Cristina Albuquerque Douberin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Objective: This study aims to associate the most prevalent side effects with the duration of chemotherapy treatment of women with breast cancer assisted at the Pernambuco Cancer Hospital. Materials and Methods: This was a descriptive, cross-sectional study with a quantitative approach, conducted at the Outpatient Unit of a specialized clinic for breast pathology at the Pernambuco Cancer Hospital (PCH). The data collection procedure was performed by applying the Free and Informed Consent Term (FICT) and subsequently a collection instrument with information on the clinical treatment of women. Results: The study results revealed that a considerable portion of women, 192 of them (60.6%), received the diagnosis less than a year ago. When asked if they felt any kind of symptom, 284 patients (89.6%) stated that they had already felt or were feeling at the moment, among them, 238 (83.8%) indicated fatigue (tiredness) as a predominant symptom, followed by of nausea, which featured 218 markings (76.8%). Conclusion: Finally, it is clear that the symptoms, in general, became more prevalent in the lives of patients who had had few chemotherapy sessions.